DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Anagrelide
Anagrelide
Photoaging & Skin Damage
Late Stent Thrombosis After Paclitaxel-Eluting Stent Placement in a Patient with Essential Thrombocytosis
May 2020 for Health Professionals Who Care for Cancer Patients
BC Cancer Benefit Drug List September 2021
Anagrelide
Xagrid, INN-Anagrelide
ER Guide to Bleeding Disorders
Hydroxyurea Induced Oscillations in Twelve Patients with Polycythemia
Pharmaceuticals As Environmental Contaminants
Preoperative Medication Directive a Clinical Practice Protocol Practitioner Information
Cancer Drug Counselling: a Guide for Pharmacists
3 Recent Actions by the Food And
Product List 2019 Finished Dosage Forms (Partner Label), Active Pharmaceutical Ingredients
Lists of Medicinal Products for Rare Diseases in Europe*
Specialty Pharmacy Drug List
Information for the Patient Anagrelide 0.5 Mg Hard Capsules Read All Of
Anagrelide Is Effective in Treating Patients with Hydroxyurea-Resistant Thrombocytosis in Patients with Chronic Myeloid Leukemia
Long-Term Management of Thrombocytosis in Essential Thrombocythaemia Gunnar Birgegård
Top View
BCBSNM/HMONM Therapeutic Class Drug List (Formulary) 2004
Appendix B - Product Name Sorted by Applicant
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
A Phase 2 Study of Combination Therapy with Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Myelodysplastic Syndromes Or Secondary Acute Myeloid Leukemia
Chemotherapy Drugs
Myeloproliferative Disorders
Busulfan Information and a Dv Ice Supporting Patients MPN Voice and Families Affected Previously Known As MPD Voice by MPN
Brand Generic Guide
Study Protocol
Anticoagulants (Blood Thinners)
Specialty Pharmacy Drug List
1 INTRODUCTION the Information Contained in the Umpqua Health Alliance (UHA) Formulary and Its Appendices Is Provided for the Co
Preoperative Guidelines for Medications Prior to Surgery
FEP 5 Tier Rx Drug Formulary (607) Standard Option
Outpatient Cancer Drug Benefit Program List
Combination Therapy of Hydroxycarbamide with Anagrelide
Auxiliary Label List
Anagrelide Information and a Dv Ice Supporting Patients MPN Voice and Families Affected Previously Known As MPD Voice by MPN
Sp-026 How I Treat Essential Thrombocythemia
Anagrelide: 20 Years Later
RED List of Drugs for HERPC
2056.00 Fred Hutchinson Cancer
(12) United States Patent (10) Patent No.: US 7,510,710 B2 Newell Et Al
Product Monograph Including Patient Medication Information
AGRYLIN (Anagrelide Hydrochloride)
Specialty Pharmacy Drug List
Anagrelide a Review of Its Use in the Management of Essential Thrombocythaemia
Clinical Guidelines, and Clinical Studies of Interest
Chemotherapy Drugs
Comparison Between Anagrelide and Hydroxycarbamide in Their Activities
2012 ESMO Handbook of Clinical Pharmacology of Anti-Cancer Agents
(12) Patent Application Publication (10) Pub. No.: US 2009/0324710 A1 Glidden Et Al
Bone Marrow Failure Syndromes: (Fig 1), and What They Comprise • Absence of Abnormal Cells in the Bone Marrow Failure Syndromes Are Bone Marrow
Myelofibrosis Facts No
Volume , Number
Bring Pharmacists Into The
Agrylin® Capsules
Impact of Celecoxib Restrictions in Medicare Beneficiaries with Arthritis
Committee for Medicinal Products for Human Use (CHMP) Minutes of the Meeting on 20-23 March 2017
(12) United States Patent (10) Patent No.: US 9,381,198 B2 Glidden Et Al
Minutes PRAC Meeting on 14 -17 April 2020
New Zealand Data Sheet
Tyrosine Kinase-Targeting Drugs-Associated Heart Failure